openPR Logo
Press release

Point of Care Molecular Diagnostics Market is Expected to Grow at a CAGR of 13% to Reach at $2.32 Billion by 2027 |Revenue Growth Analysis and Top Companies

03-03-2020 02:43 PM CET | Health & Medicine

Press release from: Meticulous Research

Point of Care (POC) Molecular Diagnostics Market

Point of Care (POC) Molecular Diagnostics Market

Meticulous Research- leading global market research company published a research report titled "Point of Care Molecular Diagnostics Market by Product & Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027".
According to this latest publication from Meticulous Research, the global POC molecular diagnostics market is expected to grow at a CAGR of 13% from 2019 to reach to $2.32 billion by 2027.

Download Free Sample Copy Of The Report:: https://www.meticulousresearch.com/download-sample-report/cp_id=5081

The high growth of point of care (POC) molecular diagnostics market is mainly attributed to the rising prevalence of chronic diseases along with significantly growing aging population, growing development and commercialization of CLIA-Waived POC molecular diagnostic tests, rising venture capital funding for development of POC molecular diagnostics products, growing demand for POC molecular diagnostics, and growing need for rapid decision making in emergency care. Moreover, emerging economies such as China, India, and Latin American countries offer significant growth opportunities for the players operating in this market. However, tedious regulatory process for high or moderate POC tests is the key factor expected to hinder the growth of the overall POC molecular diagnostics market to a certain extent.

Key questions answered in the report-

1 Which are the high growth market segments in terms of product & solution, technology, application, end-users, and region/countries?
2 What was the historical market for point of care molecular diagnostics across the globe?
3 What are the market forecasts and estimates for the period 2019-2027?
4 What are the major drivers, restraints, opportunities, and challenges in the global point of care molecular diagnostics market?
5 Who are the major players in the point of care molecular diagnostics market?
6 How is the competitive landscape and who are the market leaders in the global point of care molecular diagnostics market?
7 What are the recent developments in the global point of care molecular diagnostics market?
8 What are the different strategies adopted by the major players in the global point of care molecular diagnostics market?
9 What are the geographic trends and high growth regions/ countries?

Have Any Query? Ask Our Expert https://www.meticulousresearch.com/speak-to-analyst/cp_id=5081

The global POC molecular diagnostics market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product & solution [kits and assays, analyzers, software & services], technology [RT-qPCR, INAAT, and other technologies], application [respiratory diseases, Sexually Transmitted Diseases (STDs), Hospital Acquired Infections (HAIs), cancer/oncology, prenatal/neonatal testing, and other applications], end-user [clinics and diagnostic laboratories, hospital outpatient departments and Intensive Care Units (ICUs), research and academic institutes]. The study also evaluates industry competitors and analyzes the market at a regional and country level.

Based on technology, the RT-qPCR segment held the largest share of the overall POC molecular diagnostics market in 2019. The largest share of this segment is mainly attributed to the growing adoption of this technology over the traditional PCR technology. This technology has the ability to identify amplified fragments in real-time and is more specific, sensitive, and reproducible method. Also, the cost-effective nature of this method due to less requirement of total amount of template material for the overall assay drives the growth of this segment. Moreover, large number of commercially available RT-qPCR based POC molecular diagnostic systems or tests, increasing utilization of RT-qPCR in proteomics & genomics, and growing need for rapid diagnosis of viral & infectious diseases are some of the other factors further expected to drive the growth of this technology in future.

You Can Directly Buy This Report From Here:: https://www.meticulousresearch.com/buy_now.php?pformat=382&vformat=1133
(Get key industry insights spread across 200 pages with 116 market data tables & 40 figures & charts from the report)

Based on product and solution, the kits & assays segment accounted for the largest share of the overall POC molecular diagnostics market in 2019 and expected to grow at the highest CAGR during the forecast period of 2019-2027. Frequent usage of assays & kits, growing portfolio of disease-specific assays for early diagnosis of chronic diseases, technological advancements, and focus of key players on receiving CLIA approvals for their disease-specific advanced POC molecular diagnostic products are some of the key factors driving the growth of this market.

Based on application area of POC molecular diagnostics, the respiratory diseases segment commanded the largest share of the overall market in 2019, while, the oncology segment is expected to grow at the fastest CAGR during the forecast period. The factors such as rising number of cases with various types of cancer, growing demand for the advanced products for early diagnosis of cancer cases, and growing R&D activities within the oncology area are expected to propel the growth of the POC diagnostics market for this segment.

Based on the end user, the clinics and diagnostic laboratories segment commanded the largest share of overall POC molecular diagnostic market in 2019. This is primarily attributed to the factors such as growing need for rapid and accurate diagnosis within less time span, growing number of physicians adopting POC technologies, and increasing focus of key companies on offering disease specific POC molecular diagnostics to cater larger customer base.

Check complete table of contents with a list of table and figures: https://www.meticulousresearch.com/product/point-of-care-molecular-diagnostics-market-5081/

Geographical Analysis::
Geographically, North America dominated the overall POC molecular diagnostics market in 2019, followed by Europe and Asia Pacific. The factors such as growing awareness about the early diagnosis of chronic diseases, rising number of cases with infectious diseases, increasing venture capital funding, development and commercialization of CLIA-waived tests/systems, and strong presence of key players in this region supported the largest share of North America in the POC molecular diagnostics market.

The key players operating in the global POC molecular diagnostics market are Alere Inc. (U.S.), DxNA, LLC. (U.S.), Mesa Biotech Inc. (U.S.), Meridian Bioscience Inc. (U.S.), Danaher Corporation (U.S.), Quidel Corporation (U.S.), Biocartis Group NV (Belgium), bioMrieux SA (France), Thermo Fisher Scientific (U.S.), and F. Hoffmann-La Roche Ltd. (Switzerland), among others.

Download Free Sample Copy Of The Report:: https://www.meticulousresearch.com/download-sample-report/cp_id=5081

1 Point of Care Diagnostics Market by Test (Glucose, Cardiac, HbA1c, HIV, STD, HCV, Pregnancy, Cancer, Hematology), Platform (Immunoassay, Microfluidics, MDx), Mode (Prescription, OTC), End-User (Hospital, At Home, OPD) - Global Forecast To 2024

2 Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology and Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End-User (Hospital, CRO) - Global Forecast to 2024

Contact Us:
Meticulous Research
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

The name of our company defines our services, strengths, and values. Since the inception, we have endeavoured to research, analyze and present the critical market data with great attention to details.

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Point of Care Molecular Diagnostics Market is Expected to Grow at a CAGR of 13% to Reach at $2.32 Billion by 2027 |Revenue Growth Analysis and Top Companies here

News-ID: 1952964 • Views:

More Releases from Meticulous Research

The Cloud Managed Services Market is projected to reach $247.5 billion by 2030
The Cloud Managed Services Market is projected to reach $247.5 billion by 2030, growing at a robust CAGR of 14.2% from 2023 to 2030. This growth is fueled by advancements in cloud technologies, increasing demand in sectors like BFSI and healthcare, and a rising focus on customized and managed cloud services. However, challenges such as high costs, security risks, compliance issues, and limited flexibility may impact market growth. Download free
Language Learning Market Projected to Reach $124.6 Billion by 2031
Meticulous Research® recently published a report titled, "Language Learning Market by Age Group (40 years), Language (English, Mandarin, Spanish, French, German, Italian, Japanese), End User (B2C, B2B), and Geography - Global Forecast to 2031." Download sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5561 According to the report, the language learning market is anticipated to reach $124.6 billion by 2031, growing at a CAGR of 10.7% from 2024 to 2031. Key factors fueling this growth
Oncology Information Systems Market to be Worth $4.45 Billion by 2030: Analytica …
Introduction: Meticulous Research® recently released a comprehensive report titled "Oncology Information Systems Market By Offering (Software, Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030." The report reveals that the oncology information systems (OIS) market is projected to reach approximately $4.45 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.4% from 2024. This growth is
IoT Sensors Market to be Worth $56.8 Billion by 2030
IoT Sensors Market to be Worth $56.8 Billion by 2030
Meticulous Research®-a leading global market research company, published a research report titled, 'IoT Sensors Market by Offering (Image Sensors, RFID Sensors, Biosensors, Humidity Sensors, Optical Sensors, Others), Technology (Wired, Wireless), Sector (Manufacturing, Retail, Consumer Electronics, Others), & Geography - Global Forecast to 2030.' According to this latest publication from Meticulous Research®, in terms of value, the IoT sensors market is projected to reach $56.8 billion by 2030, at a CAGR of

All 5 Releases


More Releases for POC

Primary Catalyst Driving POC Medical Imaging Market Evolution in 2025: Chronic D …
What market dynamics are playing a key role in accelerating the growth of the poc medical imaging market? The escalating occurrence of long-term diseases is predicted to boost the expansion of the point-of-care medical imaging market in the future. The chronic disease prevalence pertains to the fraction or the count of people in a community affected by enduring health ailments at any given moment. This transition originates from lifestyle options, inherited
Transforming the Point-of-Care (POC) Coagulation Testing Market in 2025: Cardiov …
"What Is the Expected Size and Growth Rate of the Point-of-Care (POC) Coagulation Testing Market? The point-of-care (POC) coagulation testing market has grown significantly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025, at a CAGR of 5.8%. The growth is driven by increasing patient demand, the growing trend of point-of-care testing, high reliability in coagulation status testing, automation, integration with electronic health records
POC Diagnostic Testing Devices | 1drop
1drop Inc.'s POC diagnostic testing devices are essential tools in modern healthcare, designed to deliver quick and accurate results for various health conditions at the point of care. These devices make diagnostics more accessible and timelier, enhancing healthcare delivery and patient outcomes. Point-of-Care Molecular Diagnostic Platform 1drop offers a comprehensive POC molecular diagnostic platform that consists of three main components: • Reagent: Specialized reagents formulated for specific tests, including molecular diagnostics. • Device: The 1POT™ Duo
POC Diagnostics Market Size 2024 to 2031.
Market Overview and Report Coverage POC, or Point of Care, Diagnostics refer to medical tests that are performed outside of a traditional laboratory setting, allowing for quicker results and immediate treatment decisions. The POC Diagnostics Market encompasses a wide range of diagnostic tests including blood glucose monitoring, pregnancy tests, infectious disease testing, and more. The future outlook of the POC Diagnostics Market is optimistic, with the market expected to grow
Point of Care (POC) Coagulation Testing Devices Market - Transforming Coagulatio …
Newark, New Castle, USA: The "Point of Care (POC) Coagulation Testing Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Point of Care (POC) Coagulation Testing Devices
POC Cardiovascular Diagnostic Market 2022 | Detailed Report
According to Market Study Report, POC Cardiovascular Diagnostic Market provides a comprehensive analysis of the POC Cardiovascular Diagnostic Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5467652 The report provides a comprehensive analysis of company profiles listed below: - Abbott - Biomerieux - Danaher - F.